Capstone Holding Corp. — Director's Dealing 2011

Jan 18, 2011

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Capstone Therapeutics Corp. (CAPS)
CIK: 0000887151
Period of Report: 2011-01-17

Reporting Person: Shinbaum Dana B (VP Business Development)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2011-01-17	Stock Option (Right to Buy)	$0.67	A	25000	Acquired	2021-01-17	Common Stock (25000)	Direct

Footnotes

F1: The options vest in twenty-four equal installments beginning 1/17/11